Letter to the Editor regarding “Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery”

Saved in:
Bibliographic Details
Main Authors: Parth Aphale, Himanshu Shekhar, Shashank Dokania
Format: Article
Language:English
Published: Elsevier 2025-10-01
Series:American Heart Journal Plus
Online Access:http://www.sciencedirect.com/science/article/pii/S2666602225000941
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849339226015924224
author Parth Aphale
Himanshu Shekhar
Shashank Dokania
author_facet Parth Aphale
Himanshu Shekhar
Shashank Dokania
author_sort Parth Aphale
collection DOAJ
format Article
id doaj-art-c8a7095817374170962388ef3b61899e
institution Kabale University
issn 2666-6022
language English
publishDate 2025-10-01
publisher Elsevier
record_format Article
series American Heart Journal Plus
spelling doaj-art-c8a7095817374170962388ef3b61899e2025-08-20T03:44:11ZengElsevierAmerican Heart Journal Plus2666-60222025-10-015810059110.1016/j.ahjo.2025.100591Letter to the Editor regarding “Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery”Parth Aphale0Himanshu Shekhar1Shashank Dokania2D.Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra, India; Corresponding author.D.Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra, IndiaD.Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra, Indiahttp://www.sciencedirect.com/science/article/pii/S2666602225000941
spellingShingle Parth Aphale
Himanshu Shekhar
Shashank Dokania
Letter to the Editor regarding “Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery”
American Heart Journal Plus
title Letter to the Editor regarding “Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery”
title_full Letter to the Editor regarding “Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery”
title_fullStr Letter to the Editor regarding “Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery”
title_full_unstemmed Letter to the Editor regarding “Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery”
title_short Letter to the Editor regarding “Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery”
title_sort letter to the editor regarding clinical benefit and cost effectiveness of adding life time low dose colchicine as secondary prevention following coronary artery bypass grafting surgery
url http://www.sciencedirect.com/science/article/pii/S2666602225000941
work_keys_str_mv AT parthaphale lettertotheeditorregardingclinicalbenefitandcosteffectivenessofaddinglifetimelowdosecolchicineassecondarypreventionfollowingcoronaryarterybypassgraftingsurgery
AT himanshushekhar lettertotheeditorregardingclinicalbenefitandcosteffectivenessofaddinglifetimelowdosecolchicineassecondarypreventionfollowingcoronaryarterybypassgraftingsurgery
AT shashankdokania lettertotheeditorregardingclinicalbenefitandcosteffectivenessofaddinglifetimelowdosecolchicineassecondarypreventionfollowingcoronaryarterybypassgraftingsurgery